Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England.
Features
Why UK NEQAS does what it does: it’s all about the patients
Dr Deborah Pritchard and Dr Gwen Wark, members of the UK NEQAS Board, explain how UK NEQAS gives users the confidence that they are providing the best results for their assays, and clinical teams and patients the reassurance that they are receiving the correct information to manage health conditions and treatment.
Revolutionising laboratories with sthemO and sthemE haemostasis systems
Stago’s new high-throughput sthemO and sthemE haemostasis systems deliver better patient care, improve productivity, and reduce staff pressure – making them the ideal solutions for addressing urgent NHS coagulation laboratory challenges.
Latest Issues
Your partner for equipment and consumables for medicine and science
Sarstedt, one of the world's leading providers of laboratory and medical equipment, develops, manufactures and sells equipment and consumables in the field of medicine and science.
Founded in 1961, the company has continued to grow to the point where it now employs a...
The British Association for Cytopathology Annual Scientific Meeting
Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024
UK NEQAS: Navigating Quality Standards in Point of Care Testing
The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024
Pathology Visions 24
Hyatt Regency, Orlando, FL
3-5 November, 2025
Medica
Messe Dusseldorf
11-14 November, 2024
POCT-for-Scot: Bringing the future to you
SEC Arena, Glasgow
14 November, 2024